TORONTO, June 16, 2025 ( GLOBE NEWSWIRE ) -- Blue Moon Metals Inc. ( "Blue Moon" or the "Company" ) ( TSXV: MOON. OTCQX: BMOOF ) , is pleased to announce that the company has commenced underground construction on the Nussir Mine completing the first blast on the access portal on June 12, 2025.

MIAMI BEACH, Fla., June 16, 2025 ( GLOBE NEWSWIRE ) -- AirSculpt Technologies, Inc. ( "AirSculpt" ) ( NASDAQ: AIRS ) , a national provider of premium body contouring procedures, today announced the voluntary prepayment of $10.0 million of its outstanding term loan debt using cash on hand, ...

LONDON, June 16, 2025 /PRNewswire/ -- International Game Technology PLC IGT announced today that it recently signed a new, three-year sports betting technology agreement with Boyd Gaming Corporation.

Announcement marks the third phase of USD 100 million share buyback program ...

ZUG, Switzerland, June 16, 2025 ( GLOBE NEWSWIRE ) -- Pharvaris ( Nasdaq: PHVS ) , a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema ( HAE ) ...

Sarepta shares fell ~40% in premarket after reporting a second patient death linked to Elevidys. Sarepta halted Elevidys shipments for non-ambulatory patients and paused dosing in the ENVISION trial. 9 Out of the Last 10 Summers this "Power Pattern" Delivered Winners - Get The Details Now.

BEDFORD, Mass., June 16, 2025 ( GLOBE NEWSWIRE ) -- Ocular Therapeutix, Inc. OCUL "Ocular" ) ) , a fully-integrated biopharmaceutical company committed to redefining the retina experience, today announced participation at Clinical Trials at the Summit 2025, taking place on June 21, 2025, in Las ...

- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -This follows another recent authorization by Anthem Multiplan for PoNS Device at out-of-network negotiated price of $19,160-

BEDFORD, Mass., June 16, 2025 ( GLOBE NEWSWIRE ) -- Ocular Therapeutix, Inc. ( NASDAQ: OCUL, "Ocular" ) , a fully-integrated biopharmaceutical company committed to redefining the retina experience, today announced participation at Clinical Trials at the Summit 2025, taking place on June 21, ...

Ampere Metals to acquire Virginia Project for a total consideration of US$ 8.0 million: US$5 million for the sale of the mineral rights and US$3 million for the sale of the landholdings over 5 years of scheduled payments